Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists

Details for Australian Patent Application No. 2002211923 (hide)

Owner Depomed, Inc.

Inventors Cowles, Verne E.

Agent FB Rice

Pub. Number AU-B-2002211923

PCT Pub. Number WO02/32416

Priority 09/691,398 17.10.00 US

Filing date 16 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 1 December 2005

International Classifications

A61K 031/00

Event Publications

1 December 2005 Application Accepted

  Published as AU-B-2002211923

30 March 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211924

2002211922-Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of HIV infection with HIV protease inhibitors